← Back to headlines
Arrowhead Pharmaceuticals Upgraded by Morgan Stanley
Arrowhead Pharmaceuticals has received an upgrade from Morgan Stanley, citing upcoming catalysts as the reason for the improved rating.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
